Literature DB >> 16400022

A dynamic relationship between intracellular and extracellular pools of Abeta.

Salvatore Oddo1, Antonella Caccamo, Ian F Smith, Kim N Green, Frank M LaFerla.   

Abstract

The accumulation of the amyloid-beta peptide (Abeta) in the brain is considered to have a primary role in Alzheimer's disease (AD). In addition to the extracellular accumulation of Abeta in the parenchyma and cerebrovasculature, emerging evidence indicates that intraneuronal Abeta also plays a pathophysiological role in AD. It is unclear, however, if the intracellular and extracellular pools of Abeta are unrelated or connected. In these studies, we sought to establish a relationship between these two pools of Abeta. We identified an inverse relationship between intracellular and extracellular Abeta in the 3xTg-AD transgenic model of AD. Using an immunotherapy approach, we further found that extracellular Abeta was cleared before intracellular Abeta. After the antibody dissipated, however, the reappearance of extracellular plaques was preceded by the accumulation of intraneuronal Abeta. Taken together, these results provide strong experimental evidence that intraneuronal Abeta may serve as a source for some of the extracellular amyloid deposits.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400022      PMCID: PMC1592652          DOI: 10.2353/ajpath.2006.050593

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

1.  Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

Authors:  Salvatore Oddo; Antonella Caccamo; Jason D Shepherd; M Paul Murphy; Todd E Golde; Rakez Kayed; Raju Metherate; Mark P Mattson; Yama Akbari; Frank M LaFerla
Journal:  Neuron       Date:  2003-07-31       Impact factor: 17.173

2.  Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease.

Authors:  Ian F Smith; Brian Hitt; Kim N Green; Salvatore Oddo; Frank M LaFerla
Journal:  J Neurochem       Date:  2005-09       Impact factor: 5.372

Review 3.  Amyloid beta-peptide: the inside story.

Authors:  Bertrand P Tseng; Masashi Kitazawa; Frank M LaFerla
Journal:  Curr Alzheimer Res       Date:  2004-11       Impact factor: 3.498

4.  Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells.

Authors:  D G Cook; M S Forman; J C Sung; S Leight; D L Kolson; T Iwatsubo; V M Lee; R W Doms
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

5.  Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

Authors:  T Hartmann; S C Bieger; B Brühl; P J Tienari; N Ida; D Allsop; G W Roberts; C L Masters; C G Dotti; K Unsicker; K Beyreuther
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

6.  Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.

Authors:  Antonella Caccamo; Salvatore Oddo; Michael C Sugarman; Yama Akbari; Frank M LaFerla
Journal:  Neurobiol Aging       Date:  2005-05       Impact factor: 4.673

7.  Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease.

Authors:  Salvatore Oddo; Antonella Caccamo; Kim N Green; Kevin Liang; Levina Tran; Yiling Chen; Frances M Leslie; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-10       Impact factor: 11.205

8.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

9.  Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.

Authors:  Salvatore Oddo; Antonella Caccamo; Masashi Kitazawa; Bertrand P Tseng; Frank M LaFerla
Journal:  Neurobiol Aging       Date:  2003-12       Impact factor: 4.673

10.  Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture.

Authors:  D M Skovronsky; R W Doms; V M Lee
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

View more
  106 in total

Review 1.  Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells.

Authors:  Silke Brunholz; Sangram Sisodia; Alfredo Lorenzo; Carole Deyts; Stefan Kins; Gerardo Morfini
Journal:  Exp Brain Res       Date:  2011-09-30       Impact factor: 1.972

2.  Following activation of the amyloid cascade, apolipoprotein E4 drives the in vivo oligomerization of amyloid-β resulting in neurodegeneration.

Authors:  Haim Belinson; Zehavit Kariv-Inbal; Rakez Kayed; Eliezer Masliah; Daniel M Michaelson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Methylene blue reduces aβ levels and rescues early cognitive deficit by increasing proteasome activity.

Authors:  David X Medina; Antonella Caccamo; Salvatore Oddo
Journal:  Brain Pathol       Date:  2011-03       Impact factor: 6.508

4.  Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure.

Authors:  Robin Altman; Sonny Ly; Silvia Hilt; Jitka Petrlova; Izumi Maezawa; Tamás Kálai; Kálmán Hideg; Lee-Way Jin; Ted A Laurence; John C Voss
Journal:  Biochim Biophys Acta       Date:  2015-09-14

Review 5.  Beta-amyloid modulation of synaptic transmission and plasticity.

Authors:  Deepa V Venkitaramani; Jeannie Chin; William J Netzer; Gunnar K Gouras; Sylvain Lesne; Roberto Malinow; Paul J Lombroso
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

6.  Peptide aggregation in finite systems.

Authors:  Gurpreet Singh; Ivan Brovchenko; Alla Oleinikova; Roland Winter
Journal:  Biophys J       Date:  2008-07-11       Impact factor: 4.033

7.  Oligomerization Alters Binding Affinity Between Amyloid Beta and a Modulator of Peptide Aggregation.

Authors:  Silvia Hilt; Tatu Rojalin; Tapani Viitala; Artturi Koivuniemi; Alex Bunker; Sebastian Wachsmann Hogiu; Tamás Kálai; Kálmán Hideg; Marjo Yliperttula; John C Voss
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2017-10-10       Impact factor: 4.126

8.  Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability.

Authors:  Antonella Caccamo; Smita Majumder; Janice J Deng; Yidong Bai; Fiona B Thornton; Salvatore Oddo
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

Review 9.  Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies.

Authors:  Einar M Sigurdsson
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

Review 10.  Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.

Authors:  Thomas L Platt; Valerie L Reeves; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.